An Evaluation of Combinations of Diaziquone, Etoposide and Mitoxantrone in the Treatment of Adults With Relapsed or Refractory Acute Myeloid Leukemia: Results of 8722, a Randomized Phase II Study Conducted by Cancer and Leukemia Group B

Leukemia - United Kingdom
doi 10.1038/sj.leu.2400905
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

High Dose Cytarabine Plus Gemtuzumab Ozogamicin for Patients With Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902

Leukemia Research
Cancer ResearchOncologyHematology
2011English

A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Cyclosporine Modulation of Multidrug Resistance in Combination With Pravastatin, Mitoxantrone and Etoposide for Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase 1/2 Study

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Cyclosporine Modulation of Multidrug Resistance in Combination With Pravastatin, Mitoxantrone, and Etoposide for Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML): A Phase 1/2 Study

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Gemtuzumab Ozogamicin in Children With Relapsed or Refractory Acute Myeloid Leukemia: A Report of Berlin-Frankfurt-Münster Study Group

Haematologica
Hematology
2018English

A Multi-Center Phase I Study of Clofarabine, Etoposide and Cyclophosphamide in Combination in Pediatric Patients With Refractory or Relapsed Acute Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

The mTOR Inhibitor Everolimus in Combination With Azacitidine in Patients With Relapsed/Refractory Acute Myeloid Leukemia: A Phase Ib/Ii Study

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy